-
41
Novel tumour antigens and the development of optimal vaccine design
Published 2018-04-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
42
Evaluation of two commercially-available vaccines on in the peripheral lymph nodes of experimentally-infected cattle
Published 2020-10-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
43
Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review
Published 2023-04-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
44
Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing
Published 2020-02-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
45
Insights into innate and adaptive immune responses in vaccine development against EV-A71
Published 2019-11-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
46
Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome
Published 2024-02-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
47
Cross-reactivity with Brazilian strains of B after immunization with outer membrane vesicles
Published 2019-12-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
48
Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran
Published 2022-11-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
49
Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19
Published 2022-03-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
50
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations
Published 2019-02-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
51
Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
Published 2022-12-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
52
Designing an inclusive immunization schedule for children and adults in India
Published 2023-11-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
53
Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
Published 2023-08-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
54
Generating CAR T cells from tumor-infiltrating lymphocytes
Published 2021-05-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
55
Transgenic T-cell receptor immunotherapy for cancer: building on clinical success
Published 2020-06-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
56
Strategies for active and passive pediatric RSV immunization
Published 2021-02-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
57
Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
Published 2018-06-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
58
T cells in SARS-CoV-2 infection and vaccination
Published 2022-08-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
59
Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy
Published 2019-08-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
60
: analysis of pili and LPS in emerging Brazilian strains
Published 2020-05-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article